Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆

T Powles, J Bellmunt, E Comperat… - Annals of …, 2022 - annalsofoncology.org
Urothelial carcinoma (UC), also described as bladder cancer, is the 10th most common
cancer type worldwide, with an estimated 549 000 new cases and 200 000 deaths in 2018 …

Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

MD Galsky, S Daneshmand, S Izadmehr… - Nature medicine, 2023 - nature.com
Cystectomy is a standard treatment for muscle-invasive bladder cancer (MIBC), but it is life-
altering. We initiated a phase 2 study in which patients with MIBC received four cycles of …

Health-related quality of life after curative treatment for muscle-invasive bladder cancer

E Grobet-Jeandin, U Pinar, J Parra, M Rouprêt… - Nature Reviews …, 2023 - nature.com
Muscle-invasive bladder cancer (MIBC) is an aggressive disease for which the gold-
standard treatment is radical cystectomy (RC) in combination with cisplatin-based …

Bladder Cancer Treatments in the Age of Personalized Medicine: A Comprehensive Review of Potential Radiosensitivity Biomarkers

C Feghaly, R Challita, HB Hadir… - Biomarker …, 2024 - journals.sagepub.com
Bladder cancer is one of the most frequently diagnosed cancers in men. While cystectomy
remains the primary treatment, advances in radiotherapy and chemotherapy have …

A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma

VM Schuettfort, D D'Andrea, F Quhal… - BJU …, 2022 - Wiley Online Library
Objectives To determine the predictive and prognostic value of a panel of systemic
inflammatory response (SIR) biomarkers relative to established clinicopathological variables …

Fractionation versus Adaptation for Compensation of Target Volume Changes during Online Adaptive Radiotherapy for Bladder Cancer: Answers from a Prospective …

C Pöttgen, C Hoffmann, T Gauler, M Guberina… - Cancers, 2023 - mdpi.com
Simple Summary Online adaptive radiotherapy (ART) allows adaptation of the dose
distribution to the anatomy captured with pre-adaptation imaging. Since ART is time …

SEOM-SOGUG clinical guideline for localized muscle invasive and advanced bladder cancer (2021)

BP Valderrama, A González-del-Alba… - Clinical and …, 2022 - Springer
Most muscle-invasive bladder cancer (BC) are urothelial carcinomas (UC) of transitional
origin, although histological variants of UC have been recognized. Smoking is the most …

Novel transurethral resection technologies and training modalities in the management of nonmuscle invasive bladder cancer: a comprehensive review

VM Schuettfort, B Pradere, E Compérat… - Current Opinion in …, 2021 - journals.lww.com
TURBT remains the quintessential procedure for the diagnosis and treatment of bladder
cancer. Urologists need to be aware of the importance and challenges of this procedure …

Urinary diversion with or without concomitant cystectomy for benign conditions: a comparative morbidity assessment according to the updated European association of …

MW Vetterlein, MJ Buhné, H Yu, J Klemm… - European Urology …, 2022 - Elsevier
Background Evidence is scarce on morbidity after urinary diversion±cystectomy as treatment
for benign bladder indications. Objective To conduct a morbidity assessment and to evaluate …

Oncologic Impact and Safety of Pre-Operative Radiotherapy in Localized Prostate and Bladder Cancer: A Comprehensive Review from the Cancerology Committee of …

P Sargos, S Supiot, G Créhange, G Fromont-Hankard… - Cancers, 2021 - mdpi.com
Simple Summary Radiotherapy may have an interesting role of reinforcing the loco-regional
control of cancer, in addition to surgery, when used as a preoperative treatment. This …